XCarb will is set to proivide $100m in funding for startups each year to support ArcelorMittal’s aim of carbon-neutral steel production.

Each Friday the Global Corporate Venturing Deal Net rounds up the week’s smaller deals and tracks the emerging companies accessing corporate funds.

VIB’s antiviral treatment developer has closed its series A round following a $22.6m extension backed by the research institute, V-Bio Ventures and Vives Inter-University Fund.

UCB’s corporate venture capital unit has helped the antiviral treatment developer close its series A round, joining a $22.6m extension.

Q&A with Priyanka Chopra, head of finance, Prosus Ventures

The Fibabanka-backed financial education provider has doubled its overall funding to $40m in a convertible note round.

Eli Lilly and Novartis Venture Fund participated in a round that will support the progress of Amphista's protein degradation drug candidates toward clinical trials.

Smile Invest and Innovation Industries Fund have co-led a $37m first tranche for TUe spinout Effect Photonics’ series C round.

Forbion and Gilde Healthcare have co-led a $53m series B round for Dundee spinout Amphista, which is working on targeted protein degradation technology.

Existing corporate investor Vorwerk Ventures contributed to an $11.9m round that will support the expansion of Rebike's e-bike rental service.